You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永泰生物-B(6978.HK)大漲13.5% 商業化進程邁出重要一步
格隆匯 02-25 16:11
格隆匯2月25日丨永泰生物-B(6978.HK)大肆上漲,盤中最高漲14.08%至15.88港元,股價創去年7月以來新高,最終收漲13.51%報15.8港元,市值超80億港元。公司今早公佈,與紹興濱海新區管委會簽訂合作框架協議及項下相關的細胞免疫治療專項產業基金有限合夥協議,其中包括擬合作建設永泰生物華東細胞產業園建設項目。該項目劍指華東市場,併為永泰生物的產品生產、渠道拓展、產業協同奠定基礎。永泰生物商業化進程,又邁出重要一步。瞭解詳情可點擊下列鏈接。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account